Anzeige
Mehr »
Donnerstag, 09.10.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQ4G | ISIN: US03843E1047 | Ticker-Symbol:
NASDAQ
08.10.25 | 21:59
6,195 US-Dollar
0,00 % 0,000
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AQUESTIVE THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
AQUESTIVE THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur AQUESTIVE THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiAquestive gains after new patent wins for Anaphylm1
MiAquestive Therapeutics, Inc. - 8-K, Current Report-
MiAquestive receives two new patents for oral anaphylaxis treatment1
AQUESTIVE THERAPEUTICS Aktie jetzt für 0€ handeln
MiAquestive Therapeutics, Inc.: Aquestive Therapeutics Broadens Patent Estate for Anaphylm46New patents extend protection for Anaphylm into 2037Anaphylm (dibutepinephrine) Sublingual Film, if approved by the FDA, will be the first and only oral medication for the rescue treatment of severe...
► Artikel lesen
01.10.Aquestive Therapeutics, Inc. - 8-K, Current Report1
23.09.ARS Pharma Urges FDA To Delay Approval Of Aquestive's Allergic Reaction Treatment6
05.09.AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA4
04.09.FDA Confirms Direct Review Path For Aquestive's Allergy Treatment6
04.09.Aquestive jumps as FDA says no AdCom for allergy therapy Anaphylm3
04.09.Aquestive Therapeutics: Anaphylm NDA Remains On Track For PDUFA Goal Date Of Jan. 313
04.09.Aquestive Therapeutics, Inc. - 8-K, Current Report1
04.09.Aquestive Therapeutics, Inc.: Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm3
26.08.Piper Sandler reiterates Overweight rating on Aquestive stock after positive survey3
19.08.Cantor Fitzgerald bekräftigt "Overweight"-Rating für Aquestive mit Kursziel 15 US-Dollar1
19.08.Cantor Fitzgerald reiterates Overweight rating on Aquestive stock at $15 target1
19.08.RTW Biotech Opp. - Strategic Funding Agreement with Aquestive-
18.08.Aquestive signs $75m agreement for launch of Anaphylm2
14.08.Aquestive Therapeutics stock rises after securing $75 million funding deal3
14.08.Aquestive Therapeutics rises after pricing $85M stock offering1
14.08.Aquestive Therapeutics prices $85 million public offering2
Weiter >>
49 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1